Literature DB >> 12550757

Evidence for another tumor suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma.

Xin Yuan Guan1, Jonathan S T Sham, Lai Shan Tai, Yan Fang, Hong Li, Qiwan Liang.   

Abstract

Loss of 17p is one of the most frequent chromosomal alterations in primary hepatocellular carcinoma (HCC). In the present study, the association between loss of 17p and TP53 mutation was analyzed in 94 primary HCC of Chinese patients. Loss of one allele at 17p13.3 distal to the TP53 gene was observed in 48 of 94 HCC (51%), whereas loss of heterozygosity (LOH) at 17p13.1 near the TP53 gene was detected in 30 of 94 HCC (32%) and TP53 mutation was detected in only 22 of 94 HCC (23%). High frequency of LOH at 17p13.3 and relatively low frequency of TP53 mutation in the present study indicate that loss of function of a putative tumor suppressor gene at 17p13.3 may play a more important role than TP53 in HCC development.

Entities:  

Mesh:

Year:  2003        PMID: 12550757     DOI: 10.1016/s0165-4608(02)00654-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

1.  Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

Authors:  Tae-Min Kim; Seon-Hee Yim; Seung-Hun Shin; Hai-Dong Xu; Yu-Chae Jung; Cheol-Keun Park; Jong-Young Choi; Won-Sang Park; Mi-Seon Kwon; Heike Fiegler; Nigel P Carter; Mun-Gan Rhyu; Yeun-Jun Chung
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

2.  Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Bridgette Williams; Robert A Fisher
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

3.  Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis.

Authors:  Andrea Luchetti; Diana Walsh; Fay Rodger; Graeme Clark; Tom Martin; Richard Irving; Mario Sanna; Masahiro Yao; Mercedes Robledo; Hartmut P H Neumann; Emma R Woodward; Farida Latif; Stephen Abbs; Howard Martin; Eamonn R Maher
Journal:  Int J Endocrinol       Date:  2015-03-25       Impact factor: 3.257

4.  Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.

Authors:  Carola Hedberg Oldfors; Diego Garcia Dios; Anna Linder; Kittichate Visuttijai; Emma Samuelson; Sandra Karlsson; Staffan Nilsson; Afrouz Behboudi
Journal:  BMC Genet       Date:  2015-07-14       Impact factor: 2.797

5.  Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.

Authors:  Phyllis Fung-Yi Cheung; Chi Wai Yip; Linda Wing-Chi Ng; Kwok Wai Lo; Nathalie Wong; Kwong Wai Choy; Chit Chow; Kui Fat Chan; Tan To Cheung; Ronnie Tung-Ping Poon; Sheung Tat Fan; Siu Tim Cheung
Journal:  Cancer Cell Int       Date:  2014-10-09       Impact factor: 5.722

6.  Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT.

Authors:  Kittichate Visuttijai; Jennifer Pettersson; Yashar Mehrbani Azar; Iman van den Bout; Charlotte Örndal; Janusz Marcickiewicz; Staffan Nilsson; Michael Hörnquist; Björn Olsson; Katarina Ejeskär; Afrouz Behboudi
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

Review 7.  Myosins as fundamental components during tumorigenesis: diverse and indispensable.

Authors:  Yan-Ruide Li; Wan-Xi Yang
Journal:  Oncotarget       Date:  2016-07-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.